Showing 3951-3960 of 4063 results for "".
- Diet Soda Linked to Increased Risk for Diabetic Retinopathyhttps://modernod.com/news/diet-soda-linked-to-increased-risk-for-diabetic-retinopathy/2476232/Drinking diet soda may increase the risk for proliferative diabetic retinopathy, according to a study published online in the September/October issue of Clinical and Experimental Ophthalmology, as
- Ocular Therapeutix Announces Completion of Debt Refinancinghttps://modernod.com/news/ocular-therapeutix-announces-completion-of-debt-refinancing/2476236/Ocular Therapeutix announced that it has closed a refinancing of its existing debt by entering into a new $25 million term loan with MidCap Financial and Silicon Valley Bank. The 5-year term loan facility allows for an expansion of the company’s prior $18 million credit facility to $25 mil
- American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Carehttps://modernod.com/news/american-academy-of-ophthalmology-calls-on-states-to-maintain-high-safety-standards-for-surgical-eye-care/2476237/The American Academy of Ophthalmology agrees with important patient safety guidelines recommended in a joint report issued by the three federal agencies that help guide the nation’s health care system. The report, authored by the three cabinet secretaries of the U.S. Departments of Health and Hum
- Oculus Presents the New ImageCam 3https://modernod.com/news/oculus-presents-the-new-imagecam-3/2479606/Oculus announced the release of the ImageCam 3 image documentation system, which features a smaller and lighter slit lamp. Measuring 29 x 29 x 48 millimeters, the camera of the ImageCam 3 weighs 47 grams. This miniature system brings advantages to routine slit lamp work. Its fast USB 3.0 connecti
- EyePoint Pharmaceuticals Added to NASDAQhttps://modernod.com/news/eyepoint-pharmaceuticals-added-to-nasdaq/2479607/EyePoint Pharmaceuticals announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI). EyePoint’s addition to the NBI will become effective prior to market open on Monday, December 24, 2018. The NASDAQ Biotechnology Index is designed to track the perform
- Bausch Health to Purchase Majority of Synergy Pharmaceuticals’ Assets, Including Trulancehttps://modernod.com/news/bausch-health-to-purchase-majority-of-synergy-pharmaceuticals-assets-including-trulance/2479614/Bausch Health announced a deal to purchase nearly all of the assets of bankrupt drugmaker Synergy Pharmaceuticals for about $200 million in cash, with the transaction including the constipation treatment Trulance (plecanatide), according to FirstWord. Bausch Health CEO Joseph Papa noted that the
- Anthem Blue Cross Blue Shield Now Covering Avedro’s Corneal Cross-Linking Procedurehttps://modernod.com/news/anthem-blue-cross-blue-shield-now-covering-avedros-corneal-cross-linking-procedure/2479624/Avedro announced that Anthem, the largest member of the Blue Cross Blue Shield Association, has issued a positive coverage policy for Avedro’s FDA-approved corneal cross-linking procedure bringing the total number of
- Ophthalmic Investment Funds Led by Retinal Gene Therapy Developershttps://modernod.com/news/ophthalmic-investment-funds-led-by-retinal-gene-therapy-developers/2476147/Ophthalmology remains one of the most active areas of medical technology investment, attracting monies from venture capitalists, public markets, large ophthalmic companies, and private equity. Market Scope just published its 2017/2018 Ophthalmic Deals Book, analyzing recent ophthalmic fund
- Study: Dietary Supplements Don’t Prevent Chronic Diseasehttps://modernod.com/news/study-dietary-supplements-dont-prevent-chronic-disease/2476158/As the US nutritional and dietary supplements market remains robust — an estimated $41.1 billion in sales in 2016 — the Academy of Nutrition and Dietetics is cautioning against the routine and indiscriminate use of these dietary add-ons, according to a Medscape
- Bayer to Cut 12,000 Jobs, Exit Vet Unit Amid Drag From Suitshttps://modernod.com/news/bayer-to-cut-12000-jobs-exit-vet-unit-amid-drag-from-suits/2479631/Bayer announced Thursday that it will cut around 1,250 jobs from its pharmaceutical division as part of a wider staff-reduction plan that will lead to the loss of about 12,000 positions from its global workforce of 118,200 employees by the end of 2021. The streamlining is part of an overhaul unde